Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2011
09/29/2011WO2011116466A1 Dna polymorphisms as molecular markers in cattle
09/29/2011WO2011087709A3 Eml4-alk translocations in lung cancer
09/29/2011WO2011080371A3 Method of discrimination of pieces of fruit according to their maturity, calibration procedure of said method and device that carries out said discrimination
09/29/2011WO2011069056A3 Antennary fucosylation in glycoproteins from cho cells
09/29/2011WO2011068956A3 Follistatin-like 3 (fstl3) levels in gestational diabetes
09/29/2011WO2011062933A3 Array-based proximity ligation association assays
09/29/2011WO2011062377A3 Apparatus and method for quantifying binding and dissociation kinetics of molecular interactions
09/29/2011WO2011059189A3 Method for identifying mesenchymal stem cells by using an anti-tm4sf1 antibody and composition thereof
09/29/2011WO2011057197A3 Integrated droplet actuator for gel electrophoresis and molecular analysis
09/29/2011WO2011057107A3 Microchamber electrochemical cell having a nanoslot
09/29/2011WO2011055968A3 Kit for detecting bacterial infection comprising novel monoclonal antibodies
09/29/2011WO2011053901A3 Magnetic nanostructures as theranostic agents
09/29/2011WO2011053894A3 Methods and apparatus for binding assays
09/29/2011WO2011053871A3 Multi-primer assay for mycoplasma detection
09/29/2011WO2011050379A9 Use of gstp1
09/29/2011WO2011050134A3 Detection and treatment of lrp4-associated neurotransmission disorders
09/29/2011WO2011043789A3 Inductive coagulation sensors and devices
09/29/2011WO2011035185A3 A microfluidic device and uses thereof
09/29/2011WO2011026200A3 Methods for diagnosing autoimmune diseases
09/29/2011WO2010132370A3 Soluble tlt-1 for the treatment and diagnosis of sepsis
09/29/2011US20110239317 Polynucleotides encoding promyostatin polypeptides
09/29/2011US20110239316 ANTI-cMET ANTIBODY
09/29/2011US20110239312 Methods of diagnosing and treating motor neuron diseases
09/29/2011US20110239311 Agonists of NR2F6 For Immunosupression
09/29/2011US20110238443 Computerized method and system for inferring genetic findings for a patient
09/29/2011US20110238323 Systems and methods for automated melting curve analysis
09/29/2011US20110237917 Calibration of glucose monitoring sensor and/or insulin delivery system
09/29/2011US20110237688 Methods and compositions related to acetylocholine receptor conjugates
09/29/2011US20110237669 Polyunsaturated Fatty Acids Interactions and Oxidative Stress Disorders
09/29/2011US20110237655 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use
09/29/2011US20110237651 Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo
09/29/2011US20110237650 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
09/29/2011US20110237649 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirtuin 1
09/29/2011US20110237560 Modulating and/or detecting activation induced deaminase and methods of use thereof
09/29/2011US20110237549 Modulators of rna riboswitches
09/29/2011US20110237518 Method for treating or preventing bladder cancer using the depdc1 polypeptide
09/29/2011US20110237513 Ltbp2 as a biomarker for renal dysfunction
09/29/2011US20110237464 Guided Mode Resonant Filter Biosensor Using a Linear Grating Surface Structure
09/29/2011US20110237461 Using phage epitopes to profile the immune response
09/29/2011US20110237459 Multiplexed Assay Using Encoded Solid Support Matrices
09/29/2011US20110237458 Drug discovery method
09/29/2011US20110237456 Biomarkers for drug-induced elongated qt interval and torsades de pointes
09/29/2011US20110237454 Marker for diagnosis of exposure to electromagnetic radiation and diagnostic kit comprising the same
09/29/2011US20110237453 Marker for diagnosis of exposure to electromagnetic radiation and diagnostic kit comprising the same
09/29/2011US20110237452 Marker for diagnosis of exposure to electromagnetic radiation and diagnostic kit comprising the same
09/29/2011US20110237451 Competitive n-hybrid system
09/29/2011US20110237450 Methods and systems of using exosomes for determining phenotypes
09/29/2011US20110237000 Method for detecting an analyte molecule
09/29/2011US20110236999 Hydrogel Nanoparticle Based Immunoassay
09/29/2011US20110236998 Methods and devices for detection of analytes using bloch surface wave-enhanced diffraction-based sensors
09/29/2011US20110236997 Methods and Reagents for Shortening Incubation Times in Hybridization Assays
09/29/2011US20110236996 Method for measuring cystatin c in human body fluid
09/29/2011US20110236995 Method for determining prostate cancer
09/29/2011US20110236994 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
09/29/2011US20110236993 Pancreatic cancer markers
09/29/2011US20110236992 Method of detecting a specific nucleophile and surface acoustic wave sensor for detecting the specific nucleophile
09/29/2011US20110236990 Automatic Analyzer and Sample Dispensing Method for the Automatic Analyzer
09/29/2011US20110236987 Gas detector tube for determining benzene
09/29/2011US20110236986 Sensor material and uses thereof to simultaneously sense two analytes
09/29/2011US20110236983 Single molecule detection and sequencing using fluorescence lifetime imaging
09/29/2011US20110236982 Analysis of mass spectral data in the quiet zones
09/29/2011US20110236969 Methods of generating variant proteins with increased host string content and compositions thereof
09/29/2011US20110236963 System and method for analyte measurement
09/29/2011US20110236962 Calibratable sensor unit for reaction vessels
09/29/2011US20110236957 Nanoparticle Labeling Reagents and Methods of Use
09/29/2011US20110236916 Methods and materials for detecting colorectal neoplasm
09/29/2011US20110236915 Zap-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (cll/sll)
09/29/2011US20110236914 Recording assay device
09/29/2011US20110236913 Compostion and kit for diagnosing immunoglobulin a nephropathy and tgbm nephropathy
09/29/2011US20110236912 Systems and methods for characterizing lupus erythematosus
09/29/2011US20110236911 Precipitating Substrate for Bio-Layer Interferometry
09/29/2011US20110236910 Prostate cancer biomarker
09/29/2011US20110236909 Laser scanning cytometry mediated analysis of therapeutic efficacy in tumors
09/29/2011US20110236908 Total plasma fvii/fviia levels as indicators of pre-eclampsia of pregnant females
09/29/2011US20110236906 Secretory protein biomarkers for high efficiency protein expression
09/29/2011US20110236905 Method for screening cattle, cattle screened, and cattle screening kit
09/29/2011US20110236904 Detection of tumor stem cells and tumor cells in epithelial-mesenchymal transition in body fluids of cancer patients
09/29/2011US20110236898 Methods for enhancing nucleic acid hybridization
09/29/2011US20110236897 Novel markers for diagnosing brain disease caused by brain injury and use thereof
09/29/2011US20110236896 Rgs2 genotypes associated with extrapyramidal symptoms induced by antipsychotic medication
09/29/2011US20110236893 Lgr5 modulators in the treatment of alopecia
09/29/2011US20110236887 Modified actinomycin-based nucleic acid stains and methods of their use
09/29/2011US20110236884 Microbubbles for affinity separation
09/29/2011US20110236879 Methods and compositions for analyte detection
09/29/2011US20110236878 Rapid Characterization of Proteins in Complex Biological Fluids
09/29/2011US20110236455 Novel Regulators of the Innate Immune System
09/29/2011US20110236427 Antagonists of NR2F6 For Augmenting The Immune Response
09/29/2011US20110236411 MHC Multimers in Tuberculosis Diagnostics, Vaccine and Therapeutics
09/29/2011US20110236409 Overlapping peptides from variable antigens, t cell populations and uses thereof
09/29/2011US20110236407 Vaccine for runting-stunting syndrome
09/29/2011US20110236392 Composition and method for treatment of preterm labor
09/29/2011US20110236386 Novel method for prediction of cardiovascular disease risk in type 2 diabetes
09/29/2011US20110236378 Non-human mammals for the production of chimeric antibodies
09/29/2011US20110236370 Genetic Alterations on Chromosomes 21q, 6q and 15q and Methods of Use Thereof for the Diagnosis and Treatment of Type I Diabetes
09/29/2011US20110236367 Rat cathespin dipeptidyl peptidase i (dppi): crystal structure and its uses
09/29/2011US20110236314 Method of detection and diagnosis of oral and nasopharyngeal cancers
09/29/2011US20110236306 Compositions and methods for the removal of biofilms
09/29/2011US20110236276 Analytical test tape instrument
09/29/2011US20110236267 Chemical and Biological Sensor
09/29/2011US20110236261 Sensing device for detecting target elements in a fluid